Brise Pharmaceuticals Raises Nearly $20M in Series Pre-A and Pre-A+ Financing
Brise Pharmaceuticals Co., LTD., a Shanghai, China-based company specializing in innovative treatments for acute and chronic pain, recently completed Pre-A and Pre-A+ financing with a total of approximately $20m.